NVG:NYE-Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund of Beneficial Interest (USD)

ETF | Medical Distribution | New York Stock Exchange

Last Closing

USD 11.92

Change

+0.01 (+0.08)%

Market Cap

USD 2.84B

Volume

0.42M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund is a closed-end investment company. Its investment objective is to provide attractive level of total return, through long-term capital appreciation and secondarily through income and gains.

Inception Date: 25/03/2002

Primary Benchmark: BBgBarc Municipal Insured TR USD

Primary Index: BBgBarc Municipal TR USD

Gross Expense Ratio: 1.5%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

Largest Industry Peers for Medical Distribution

Symbol Name Mer Price(Change) Market Cap
COR Cencora Inc. 0.00 %

N/A

USD 56.66B
CAH Cardinal Health Inc 0.00 %

N/A

USD 36.46B
MCK McKesson Corporation 0.00 %

N/A

N/A
OMI Owens & Minor Inc 0.00 %

N/A

N/A

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.81 % 0.00 %

N/A

USD 0.01B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT VanEck CEF Municipal Inco.. 0.00 % 0.40 %

N/A

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.77% 40% F 40% F
Dividend Return 1.93% 100% F 70% C-
Total Return -0.84% 40% F 45% F
Trailing 12 Months  
Capital Gain 1.19% 40% F 50% F
Dividend Return 6.04% 100% F 82% B
Total Return 7.22% 40% F 58% F
Trailing 5 Years  
Capital Gain -20.32% 20% F 18% F
Dividend Return 24.55% 100% F 64% D
Total Return 4.23% 40% F 24% F
Average Annual (5 Year Horizon)  
Capital Gain -4.93% 20% F 15% F
Dividend Return -2.05% 20% F 16% F
Total Return 2.88% 80% B- 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 21.17% 60% D- 45% F
Risk Adjusted Return -9.68% 20% F 19% F
Market Capitalization 2.84B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.